New charity investment vehicle

The backers of a new ASX-listed fund with a charity twist have a happy headache to overcome after the $500 million offering was over-subscribed in three days and well ahead of its close later this week.

Matthew Dunkley

New charity investment vehicle

October 21, 2018
The backers of a new ASX-listed fund with a charity twist have a happy headache to overcome after the $500 million offering was over-subscribed in three days and well ahead of its close later this week.
Read Transcript

The backers of a new ASX-listed fund with a charity twist have a happy headache to overcome after the $500 million offering was over-subscribed in three days and well ahead of its close later this week.

The Hearts & Minds Investments listed investment company (LIC) will invest its money in 25 high conviction stock picks partly selected off recommendations made by presenters at the November Sohn Hearts and Minds Investment Conference event in Melbourne. The remainder of the picks will come from a board of prominient fund managers who are giving their time and expertise for free.

A fixed 1.5 per cent of the fund's assets will be donated to medical charities every year.

The LIC reached the maximum subscription amount in three days meaning the offer is now oversubscribed ahead of it closing this week meaning the managers now face the challenge on deciding how to build the share register. Before the general offer opened earlier this month about $225 million was alreday spoken for by some of the biggest families in business including the Packers and the Lowys.

Peter Cooper, founder of Cooper Investor which is one of the five core funds managing the LIC, said the fact the fund was oversubscribed in three days was "extraordinary".

“The market has been very positive towards the LIC – not only because of the reputations of the fund managers behind it – but also for its charitable nature. Investors see this as an example of the industry coming together to help support medical research," he said.

"The offer is now well oversubscribed, so the company now has the challenge of how to form the register.”

 

The offer is now well oversubscribed, so the company now has the challenge of how to form the register.

Peter Cooper

 

Mr Cooper said the investments would build on Australia's global leading role in medical research.

"For every dollar invested in medical research, an average of $2.17 in health benefits is returned," he said.

Cooper Investors’ designated charities are Orygen, the National Centre of Excellence in Youth Mental Health, The Centre of Human Psychopharmacology at Swinburne University and The Mind & Brain Centre at Sydney University.

“I chose these charities because I believe that by advancing brain research, we can better understand the brain and how it functions in relation to mental health and well-being. We can also combat the stigma of brain disorders through education," he said.

The ASX has had a tough year now sitting just above where it began in January, but Mr Cooper, whose fund only invests "long", said there were still good opportunities for investment.

“Areas of interest include growing verticals within healthcare such as diagnostics and life sciences, or the ongoing digitisation of traditional sectors such as the travel industry," he said.

"We particularly like businesses with a high proportion of recurring revenues like subscription businesses or businesses selling services that customers ‘can’t go without’."

Mr Cooper said his fund "loved" to back focussed management which often meant businesses that were still "founder-led" or "family linked".

“When markets come under pressure these management teams look to be opportunistic, invest for the long term and can create enormous value during these uncertain times.”

 

For more information go to: sohnheartsandminds.com.au

 

Licensed by Copyright Agency. You must not copy this work without permission.

The backers of a new ASX-listed fund with a charity twist have a happy headache to overcome after the $500 million offering was over-subscribed in three days and well ahead of its close later this week.

The Hearts & Minds Investments listed investment company (LIC) will invest its money in 25 high conviction stock picks partly selected off recommendations made by presenters at the November Sohn Hearts and Minds Investment Conference event in Melbourne. The remainder of the picks will come from a board of prominient fund managers who are giving their time and expertise for free.

A fixed 1.5 per cent of the fund's assets will be donated to medical charities every year.

The LIC reached the maximum subscription amount in three days meaning the offer is now oversubscribed ahead of it closing this week meaning the managers now face the challenge on deciding how to build the share register. Before the general offer opened earlier this month about $225 million was alreday spoken for by some of the biggest families in business including the Packers and the Lowys.

Peter Cooper, founder of Cooper Investor which is one of the five core funds managing the LIC, said the fact the fund was oversubscribed in three days was "extraordinary".

“The market has been very positive towards the LIC – not only because of the reputations of the fund managers behind it – but also for its charitable nature. Investors see this as an example of the industry coming together to help support medical research," he said.

"The offer is now well oversubscribed, so the company now has the challenge of how to form the register.”

 

The offer is now well oversubscribed, so the company now has the challenge of how to form the register.

Peter Cooper

 

Mr Cooper said the investments would build on Australia's global leading role in medical research.

"For every dollar invested in medical research, an average of $2.17 in health benefits is returned," he said.

Cooper Investors’ designated charities are Orygen, the National Centre of Excellence in Youth Mental Health, The Centre of Human Psychopharmacology at Swinburne University and The Mind & Brain Centre at Sydney University.

“I chose these charities because I believe that by advancing brain research, we can better understand the brain and how it functions in relation to mental health and well-being. We can also combat the stigma of brain disorders through education," he said.

The ASX has had a tough year now sitting just above where it began in January, but Mr Cooper, whose fund only invests "long", said there were still good opportunities for investment.

“Areas of interest include growing verticals within healthcare such as diagnostics and life sciences, or the ongoing digitisation of traditional sectors such as the travel industry," he said.

"We particularly like businesses with a high proportion of recurring revenues like subscription businesses or businesses selling services that customers ‘can’t go without’."

Mr Cooper said his fund "loved" to back focussed management which often meant businesses that were still "founder-led" or "family linked".

“When markets come under pressure these management teams look to be opportunistic, invest for the long term and can create enormous value during these uncertain times.”

 

For more information go to: sohnheartsandminds.com.au

 

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Sydney Morning Herald, published on Oct 21, 2018. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.